Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2026: Engagement-Focused GenAI-based Chatbot for Real-Time Smoking Cessation Support

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Hong Kong

About this trial

The goal of this trial is to learn if chatbot-based instant messaging works to help smoking cessation in general adult smokers. It will also learn about the experience, attitude, and perception of using an LLM-based chatbot. The main questions it aims to answer are:

1. Will an engagement-focused LLM-based chatbot smoking cessation intervention have a non-inferior validated abstinence rate than the control group? 2. Will an LLM-based chatbot smoking cessation intervention have a non-inferior self-reported abstinence rate, smoking reduction rate, and smoking cessation services use rate than the control group?

Researchers will compare an LLM-based chatbot smoking-cessation intervention to a human-led instant messaging support group (brief advice based on AWARD and personalised active referral) to determine whether chatbot-based instant messaging support promotes smoking cessation.

Participants in the intervention group will receive:

1. AWARD advice 2. Personalised active referral 3. 12 weeks of chatbot-based instant messaging support (via WhatsApp)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Hong Kong residents aged 18 years or above

Smoke at least one cigarette (including heated tobacco products) per day or use an e-cigarette daily in the preceding 3 months

Able to communicate in Cantonese (including reading and writing Chinese)

Saliva cotinine level ≥30 ng/mL

Disqualifiers

Smokers who have communication barriers (either physical or cognitive)

Smokers who are currently participating in other smoking cessation programs or services

Trial design

Design model

Parallel

Treatments tested in this trial

  • AWARD advice

    Behavioral

    A brief (30-60 seconds) face-to-face or remote smoking cessation advice delivered using the validated AWARD model: Ask about smoking history; Warn about high health risks (accompanied by a health warning leaflet); Advise quitting as soon as possible and setting a quit date (to qualify for contest prizes); Refer to smoking cessation services using a referral card; Do it again - repeat the intervention at each follow-up, encouraging re-quitting after relapse or relapse prevention after success.

  • Brief leaflet on health warning and smoking cessation

    Behavioral

    A two-sided, colour-printed A4 leaflet covering: (1) absolute risk of death from smoking; (2) full list of diseases caused by active and second-hand smoking; (3) ten pictorial warnings of health consequences on one page for maximum impact; (4) benefits of smoking cessation; and (5) simple encouraging messages to quit.

  • Referral card

    Behavioral

    A three-folded card containing brief information and highlights of existing smoking cessation services in Hong Kong, contact methods, motivational messages, and strong supporting slogans.

  • Self-help smoking cessation booklet

    Behavioral

    A generic booklet provided covering: benefits of quitting, smoking-related diseases, methods to quit, how to handle withdrawal symptoms, a quitting declaration, and other practical tips.

  • Personalized active referral

    Behavioral

    Smokers will be introduced to various SC services in Hong Kong (via the referral card) and motivated to use them. Well-trained SC ambassadors will assist smokers in choosing their favourite or most convenient type of service. Research staff will assist participants in booking or re-booking the SC services at the 1- and 2-month follow-ups (after very brief questionnaire surveys). Participants' contact information will be forwarded to SC service providers within 7 days, and providers are expected to contact participants within 1-2 weeks. Research staff will also monitor participants' use of SC services at each follow-up (1-, 2-, 3-, and 6-month) and, at the 1- and 2-month follow-ups, assist participants in booking or rebooking appointments if necessary. Investigators shall liaise with existing service providers and seek their assistance in promptly supporting our smokers.

  • 12 weeks of chatbot-based instant messaging support

    Behavioral

    Participants in the intervention group will receive 12 weeks of instant messaging support delivered by an LLM-based chatbot (GPT-4o or newer) on WhatsApp, supporting text and audio input. Using prompt engineering, agent techniques, and Retrieval-Augmented Generation, the chatbot delivers theory-based 5As/5Rs-structured interventions alongside freeform, on-demand support, with engagement features including personalisation, proactive check-ins, and interactive Quick Commands.

  • 12 weeks of human-led instant messaging support

    Behavioral

    Participants in the control group will receive 12 weeks of instant messaging support delivered by a trained human counsellor via WhatsApp. Using the same theoretical frameworks as the chatbot intervention, the counsellor will provide real-time behavioural and psychosocial support grounded in the 5As/5Rs models, Motivational Interviewing (MI), and evidence-based Behaviour Change Techniques (BCTs). The support will be personalised according to each participant's sociodemographic characteristics, smoking patterns, quit intentions, and plans.

  • Reminder messages

    Behavioral

    WhatsApp messages on follow-up survey reminders.

Treatment groups

998 Participants
are divided into 2 treatment groups
Group A: Intervention groupExperimental treatment 7 interventions
Group B: Control groupActive comparator 7 interventions

Trial outcomes

Primary outcomes

1

Biochemically validated abstinence

Defined as exhaled CO level \<4ppm and saliva cotinine level ≤30 ng/ml

Time frame
6-month follow-up

Secondary outcomes

1

Biochemically validated abstinence

Defined as exhaled CO level \<4ppm and saliva cotinine level ≤30 ng/ml

Time frame
3-month follow-up
2

Self-reported 7-day point prevalence abstinence

Smokers who did not smoke even a puff in the 7 days preceding the follow-up

Time frame
3- and 6-month follow-ups
3

Self-reported reduction

Defined by at least 50% reduction in baseline daily number of cigarettes

Time frame
1-, 2-, 3- and 6-month follow-ups
4

Self-reported use of smoking cessation service

Use of smoking cessation service at 1-, 2-, 3- and 6-month follow-ups.

Time frame
1-, 2-, 3- and 6-month follow-ups

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The University of Hong Kong

Lead sponsor

Hong Kong Council on Smoking and Health

Collaborator

This trial is not recruiting at the moment. You can still explore other options: